These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11758138)

  • 61. Baseline cardiac output and its alterations during ibuprofen treatment for patent ductus arteriosus in preterm infants.
    Hsu KH; Wu TW; Wu IH; Lai MY; Hsu SY; Huang HW; Mok TY; Lee CC; Lien R
    BMC Pediatr; 2019 Jun; 19(1):179. PubMed ID: 31167645
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Patent ductus arteriosus in premature infants].
    Bratlid D; Farstad T
    Tidsskr Nor Laegeforen; 2009 Aug; 129(15):1455-8. PubMed ID: 19690594
    [TBL] [Abstract][Full Text] [Related]  

  • 63. "Shunt index" can be used to predict clinically significant patent ductus arteriosus in premature neonates in early post-natal life.
    Yapakçı E; Ecevit A; Törer B; Ince DA; Gökdemir M; Gülcan H; Tarcan A
    Cardiol Young; 2014 Aug; 24(4):605-9. PubMed ID: 23816200
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cost-Effectiveness Analysis of Ibuprofen Versus Indomethacin or Paracetamol for the Treatment of Patent Ductus Arteriosus in Preterm Neonates.
    Al-Shaibi S; Abushanab D; Abounahia F; Awaisu A; Al-Badriyeh D
    Curr Probl Cardiol; 2023 Sep; 48(9):101751. PubMed ID: 37088173
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Ibuprofen versus indomethacin in the treatment of patent ductus arteriosus in preterm infants].
    Gimeno Navarro A; Cano Sánchez A; Fernández Gilino C; Carrasco Moreno JI; Izquierdo Macián I; Gutiérrez Laso A; Morcillo Sopena F
    An Pediatr (Barc); 2005 Sep; 63(3):212-8. PubMed ID: 16219273
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Future Benefits of Sequential Echocardiography: Unmasking the Indications for Treatment of Patent Ductus Arteriosus in Extremely Preterm Infants.
    Olsson KW; Sindelar R
    Neonatology; 2015; 108(2):99. PubMed ID: 26068311
    [No Abstract]   [Full Text] [Related]  

  • 67. Clinical pharmacology of ibuprofen and indomethacin in preterm infants with patent ductus arteriosus.
    Pacifici GM
    Curr Pediatr Rev; 2014; 10(3):216-37. PubMed ID: 25088343
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Short versus prolonged indomethacin therapy for patent ductus arteriosus in preterm infants.
    Tammela O; Ojala R; Iivainen T; Lautamatti V; Pokela ML; Janas M; Koivisto M; Ikonen S
    J Pediatr; 1999 May; 134(5):552-7. PubMed ID: 10228288
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The fate of ductus arteriosus in infants at 23-27 weeks of gestation: from spontaneous closure to ibuprofen resistance.
    Dani C; Bertini G; Corsini I; Elia S; Vangi V; Pratesi S; Rubaltelli FF
    Acta Paediatr; 2008 Sep; 97(9):1176-80. PubMed ID: 18624987
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants.
    Adrouche-Amrani L; Green RS; Gluck KM; Lin J
    BMC Pediatr; 2012 Jan; 12():10. PubMed ID: 22284694
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Surgical Intervention in Preterm Neonates with Patent Ductus Arteriosus.
    Haw MP
    Curr Pediatr Rev; 2016; 12(2):123-5. PubMed ID: 27197954
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus in preterm infants.
    Sivanandan S; Bali V; Soraisham AS; Harabor A; Kamaluddeen M
    Am J Perinatol; 2013 Oct; 30(9):745-50. PubMed ID: 23322388
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Patent ductus arteriosus in the preterm infant: a survey of clinical practices in French neonatal intensive care units.
    Brissaud O; Guichoux J
    Pediatr Cardiol; 2011 Jun; 32(5):607-14. PubMed ID: 21360267
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Use of echocardiography to guide the duration of indomethacin treatment of patent ductus arteriosus in preterm infants.
    Bajaj R; Narasimhan R
    J Pediatr; 2010 Aug; 157(2):346; author reply 346. PubMed ID: 20553839
    [No Abstract]   [Full Text] [Related]  

  • 75. Acetaminophen for patent ductus arteriosus.
    Le J; Gales MA; Gales BJ
    Ann Pharmacother; 2015 Feb; 49(2):241-6. PubMed ID: 25352038
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nonsteroidal anti-inflammatory administration and patent ductus arteriosus ligation, a survey of practice preferences at US children's hospitals.
    Slaughter JL; Reagan PB; Bapat RV; Newman TB; Klebanoff MA
    Eur J Pediatr; 2016 Jun; 175(6):775-83. PubMed ID: 26879388
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
    Chotigeat U; Jirapapa K; Layangkool T
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Platelets and ductus arteriosus closure in neonates.
    Sallmon H; Delaney CA
    Semin Perinatol; 2023 Mar; 47(2):151719. PubMed ID: 36925318
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of oral ibuprofen and indomethacin on closure of patent ductus arteriosus in preterm infants.
    Pourarian Sh; Pishva N; Madani A; Rastegari M
    East Mediterr Health J; 2008; 14(2):360-5. PubMed ID: 18561728
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Is it possible to predict the success of pharmacological closure of persistent ductus arteriosus in prematurely born neonates?].
    Fendler W; Bernas S; Jarosik K; Piotrowski A
    Anestezjol Intens Ter; 2008; 40(3):156-61. PubMed ID: 19469116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.